Researchers have been excited about the medication , a novel dual treatment showing significant outcomes in initial trials for size loss . It acts by modulating two systems: GLP-1 and GIP, these, when https://saadlvgr403950.dbblog.net/14061447/this-new-prospect-for-size-loss